Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220070480010091
Journal of the Korean Ophthalmological Society
2007 Volume.48 No. 1 p.91 ~ p.96
The Usefulness of the Uniocular Drug Trial in the Glaucoma Eyes
Shin Hyung-Ho

Yoo Chung-Kwon
Choi Young-Jae
Kim Yong-Yeon
Abstract
Purpose: This study was undertaken to evaluate if the reduction of intraocular pressure (IOP) observed in a uniocular trial correlates with an IOP reduction observed in the fellow eye.

Methods: The study was performed on forty patients with bilateral glaucoma or suspect glaucoma who underwent a uniocular trial of 0.005% latanoprost and subsequently received the same drug in the fellow eye after 1 week. Inter-eye IOP variations were less than 3 mm Hg over two measurements, and were followed minimally for 4 weeks. The uniocular IOP reduction (IOP before medication - IOP after medication) and the net IOP reduction (IOP change in the trial eye after medication - IOP change in the fellow eye) were calculated. The uniocular IOP reduction and net IOP reduction in the trial eye was compared with the results from the fellow eye.

Results: The mean uniocular IOP reduction in the trial eye and the fellow eye were 3.6¡¾2.42 mm Hg and 2.78¡¾2.16 mm Hg, respectively (r=0.390, r2=0.152, P=0.013). The mean net IOP reduction in the trial eye and the opposing eye were 3.55¡¾1.70 mm Hg and 3.15¡¾1.83 mm Hg, respectively (r=0.782, r2=0.612, P=0.000).

Conclusions: A uniocular drug trial in patients with similar IOPs between their eyes can adequately predict the IOP lowering effect of a medication. J Korean Ophthalmol Soc 48(1):91-96, 2007
KEYWORD
Net IOP reduction, Uniocular drug trial, Uniocular IOP reduction
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø